ADMA Biologics, Inc. (ADMA)
NASDAQ: ADMA · Real-Time Price · USD
18.20
-0.01 (-0.05%)
Jul 1, 2025, 1:42 PM - Market open

ADMA Biologics Market Cap

ADMA Biologics has a market cap or net worth of $4.34 billion as of July 1, 2025. Its market cap has increased by 73.88% in one year.

Market Cap
4.34B
Enterprise Value
4.38B
1-Year Change
73.88%
Ranking
Category
Stock Price
$18.20

Market Cap Chart

Since October 17, 2013, ADMA Biologics's market cap has increased from $50.20M to $4.34B, an increase of 8,555.31%. That is a compound annual growth rate of 46.37%.

History

DateMarket Cap% Change
Jun 30, 20254.35B7.23%
Dec 31, 20244.05B296.92%
Dec 29, 20231.02B33.78%
Dec 30, 2022763.50M176.53%
Dec 31, 2021276.10M49.73%
Dec 31, 2020184.40M-22.29%
Dec 31, 2019237.30M114.17%
Dec 31, 2018110.80M-12.41%
Dec 29, 2017126.50M91.67%
Dec 30, 201666.00M-23.70%
Dec 31, 201586.50M-16.67%
Dec 31, 2014103.80M44.37%
Dec 31, 201371.90M43.23%
View and export this data all the way back to 2013. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 696.15B
Johnson & Johnson 366.71B
AbbVie 322.03B
Novo Nordisk 304.96B
UnitedHealth Group 280.41B
Novartis AG 235.85B
Abbott Laboratories 233.80B
AstraZeneca 217.42B
Market Cap Rankings